ESR1 and neoplasm: Patients baseline tumor size, lymphatic invasion, number of metastatic lymph nodes, estrogen receptor (ER)/progesterone receptor (PR) status, human epidermal growth factor receptor 2 (Her-2) status, endocrine therapy, and surgery are summarized in Table 1.